Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Global Market Value Of The Messenger Ribonucleic Acid (mRNA) Capping Enzyme Industry In 2025?
The market for messenger ribonucleic acid (mRNA) capping enzymes has experienced rapid growth in recent years. It is anticipated to increase from $0.89 billion in 2024 to $1.02 billion in 2025, at a compound annual growth rate (CAGR) of 14.6%. The historical expansion of this market stems from factors such as the advancement of molecular biology and biotechnology research, the broadening scope of genetic engineering and synthetic biology, increasing applications in vaccine research, rising government and private funding for RNA research, and the growth of biopharmaceutical manufacturing.
The market for messenger ribonucleic acid (mRNA) capping enzymes is projected to experience substantial expansion over the upcoming years. This market is set to reach a valuation of $1.73 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 14.2%. The anticipated growth during this period stems from several factors, including increased investment in RNA-based drug development, an expanding number of mRNA-based clinical trials, the broader adoption of personalized and precision medicine, a heightened emphasis on the stability and translational efficiency of mRNA, and the growing use of mRNA vaccines and therapeutics. Key trends foreseen for the forecast horizon encompass the incorporation of artificial intelligence and machine learning, progress in in-vitro transcription (IVT) technologies, the creation of advanced enzymatic capping systems, breakthroughs in synthetic cap analogs and co-transcriptional capping methods, and novel approaches in enzyme design.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28266&type=smp
What Are The Drivers Pushing New Developments In The Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market?
The messenger ribonucleic acid (mRNA) capping enzyme market is projected to expand due to the rising adoption of personalized medicine. Personalized medicine is a healthcare strategy that customizes medical treatment based on a person’s unique genetic makeup, lifestyle, and environmental influences. The embrace of personalized medicine is increasing, driven by advancements in genetic testing technologies that allow for more accurate identification of individual patient needs, leading to targeted and effective treatments. mRNA capping enzymes are valuable for personalized medicines because they enhance the stability and proper function of therapeutic mRNA, ensuring its efficient translation into proteins tailored to an individual’s treatment requirements. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 new personalized treatments for rare disease patients in 2023, representing a substantial increase from six approvals in 2022. Thus, the growing adoption of personalized medicine is fostering the growth of the messenger ribonucleic acid (mRNA) capping enzyme market.
What Are The Major Segment Types Covered In The Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market?
The messenger ribonucleic acid (mRNA) capping enzyme market covered in this report is segmented as
1) By Product Type: Recombinant Messenger Ribonucleic Acid (mRNA) Capping Enzymes, Natural Messenger Ribonucleic Acid (mRNA) Capping Enzymes
2) By Application: Research And Development, Therapeutics, Diagnostics, Other Applications
3) By End-User: Pharmaceutical And Biotechnology Companies, Research Institutions, Contract Manufacturing Organizations (CMOS)
Subsegments:
1) By Recombinant Messenger Ribonucleic Acid (mRNA) Capping Enzymes: Vaccinia Capping Enzyme (VCE), RNA Triphosphatase, Guanylyltransferase, (Guanine-N7)-Methyltransferase
2) By Natural Messenger Ribonucleic Acid (mRNA) Capping Enzymes: Cap 0 Capping Enzymes, Cap 1 Capping Enzymes, Cap 2 Capping Enzymes
Which Key Trends Are Expected To Influence The Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market In The Coming Years?
Leading companies in the messenger ribonucleic acid (mRNA) capping enzyme market are concentrating on developing advanced solutions, such as broad temperature mRNA capping solutions, to simplify logistics by eliminating the need for strict cold chain storage. These broad temperature mRNA capping solutions are engineered to keep mRNA capping enzymes stable and effective across various temperatures, supporting their use in different storage and treatment conditions. For instance, in August 2022, New England Biolabs, a US-based life sciences company, introduced the Faustovirus Capping Enzyme (FCE), a breakthrough enzymatic tool designed to overcome limitations of traditional capping methods in mRNA production. It features a single-subunit structure that combines RNA triphosphatase, guanylyltransferase, and N7-guanine methyltransferase activities in one enzyme. This enzyme provides broad temperature stability, functioning effectively from 20°C to 55°C, which allows greater flexibility in reaction conditions. The system utilizes a novel viral enzyme platform to produce Cap-0 structures and enables easy one-pot synthesis of Cap-1 structures when used together with NEB’s 2′-O-methyltransferase. This solution integrates smoothly into current mRNA production workflows, offering high capping efficiency, reducing enzyme use by up to half compared to traditional methods, and removing the need for harmful organic solvents.
Which Key Market Players Are Investing In Expansion And Innovation Of Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market?
Major companies operating in the messenger ribonucleic acid (mrna) capping enzyme market are Roche AG, Thermo Fisher Scientific Inc., Merck KGaA, Takara Bio Inc., Aldevron, New England Biolabs Inc., CellScript Inc., Krishgen Biosystems, Yeasen Biotechnology Co. Ltd., Novoprotein Scientific Inc., TriLink Biotechnologies LLC, Jena Bioscience GmbH, OZ Biosciences, SBS Biotech Ltd., Vazyme Biotech Co. Ltd., Enzynomics Inc., Creative Enzymes, Canvax Biotech SL, APExBIO Technology LLC, BOC Sciences, KACTUS Biosystems.
Download The Full Report For Exclusive Market Findings:
What Are The Regional Market Dynamics Impacting The Messenger Ribonucleic Acid (mRNA) Capping Enzyme Industry?
North America was the largest region in the messenger ribonucleic acid (mRNA) capping enzyme market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in messenger ribonucleic acid (mRNA) capping enzyme report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Request A Customized Version Of The Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market Report:
https://www.thebusinessresearchcompany.com/customise?id=28266&type=smp
Browse Through More Reports Similar to the Global Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market 2025, By The Business Research Company
Messenger Ribonucleic Acid Mrna Synthesis Raw Materials Global Market Report 2025
Mrna Therapeutics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/mrna-therapeutics-global-market-report
Ribonucleic Acid Rna Sequencing Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model